Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

United Therapeutic (UTHR)

United Therapeutic (UTHR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,145,883
  • Shares Outstanding, K 44,012
  • Annual Sales, $ 1,449 M
  • Annual Income, $ -104,500 K
  • 60-Month Beta 0.86
  • Price/Sales 3.58
  • Price/Cash Flow N/A
  • Price/Book 1.76

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 2.41
  • Number of Estimates 3
  • High Estimate 2.63
  • Low Estimate 2.16
  • Prior Year 4.66
  • Growth Rate Est. (year over year) -48.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
112.91 +3.83%
on 06/15/20
127.79 -8.26%
on 06/25/20
-5.63 (-4.58%)
since 06/10/20
3-Month
94.26 +24.37%
on 04/16/20
127.79 -8.26%
on 06/25/20
+21.36 (+22.28%)
since 04/09/20
52-Week
74.31 +57.76%
on 07/23/19
127.79 -8.26%
on 06/25/20
+38.10 (+48.15%)
since 07/10/19

Most Recent Stories

More News
Senhwa Biosciences's Silmitasertib Receives Rare Pediatric Disease Designation from U.S. FDA for Treatment of Recurrent Sonic Hedgehog Medulloblastoma

, /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on Next Generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today...

UTHR : 116.85 (-0.06%)
5 Stocks Trading Near 52-Week High That Can Scale Higher

Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.

MU : 50.05 (+0.14%)
UTHR : 116.85 (-0.06%)
QGEN : 45.15 (+1.35%)
AMKR : 12.21 (-2.01%)
BGS : 24.86 (+1.68%)
United Therapeut Rises 1.19% on Heavy Volume: Watch For Potential Pullback

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $119.55 to a high of $120.73. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high...

UTHR : 116.85 (-0.06%)
United Therapeut Set to Possibly Pullback After Yesterday's Rally of 1.19%

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $119.55 to a high of $120.73. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high...

UTHR : 116.85 (-0.06%)
CrazyCap helps Martine Rothblatt Cheer On Her Team Through Crisis!

, /PRNewswire/ -- Esteemed lawyer, author, and entrepreneur, , Ph.D., found a thoughtful and practical way to thank her employees at United Therapeutics, who have been going above and beyond during this...

UTHR : 116.85 (-0.06%)
Look for Shares of United Therapeut to Potentially Pullback after Yesterday's 3.58% Rise

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $115.41 to a high of $118.72. Yesterday, the shares gained 3.6%, which took the trading range above the 3-day high...

UTHR : 116.85 (-0.06%)
United Therapeutics Announces Increase Data Presentation at an American Thoracic Society Virtual Session

and , /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that key data from the study of Tyvaso (treprostinil) Inhalation Solution in patients suffering from World Health...

UTHR : 116.85 (-0.06%)
5 Stocks Trading Near 52-Week High That Can Scale Higher

Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.

UTHR : 116.85 (-0.06%)
QGEN : 45.15 (+1.35%)
BGS : 24.86 (+1.68%)
VIPS : 22.08 (-2.30%)
SPTN : 20.60 (+1.78%)
Liquidia Responds to United Therapeutics Corporation Lawsuit Alleging Infringement of Tyvaso Patents

Liquidia Technologies, Inc. (Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products utilizing its proprietary PRINT(R) technology,...

UTHR : 116.85 (-0.06%)
LQDA : 7.43 (-0.13%)
United Therapeutics Corporation Files Lawsuit Against Liquidia For Infringement Of Tyvaso Patents

and , /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it has filed a lawsuit in the U.S. District Court for the District of Delaware against Liquidia Technologies,...

UTHR : 116.85 (-0.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade UTHR with:

Business Summary

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability....

See More

Key Turning Points

2nd Resistance Point 119.72
1st Resistance Point 118.32
Last Price 116.85
1st Support Level 115.72
2nd Support Level 114.52

See More

52-Week High 127.79
Last Price 116.85
Fibonacci 61.8% 107.36
Fibonacci 50% 101.05
Fibonacci 38.2% 94.74
52-Week Low 74.31

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar